Skip to main content
Livermore
Livermore
ZHEN

Matisse Capital

SEC CIK
0001668256
Latest filing
Aug 12, 2026

ASND holding history

Ascendis Pharma A/S in every 13F filed by Matisse Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ASND overviewAll 13F holders of ASNDFull Q2 2026 holdings

Shares (Q2 2026)
28,107
Value
$7.50M
% of portfolio
3.0%
Quarters held
22
Since Q1 2021
Holdings of ASND by Matisse Capital, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202628,107$7.50M3.0%+2,030+7.8%AddedHolders
Q1 202626,077$5.96M2.6%−1,228−4.5%ReducedHolders
Q4 202527,305$5.82M2.6%+1,285+4.9%AddedHolders
Q3 202526,020$5.17M2.3%−1,922−6.9%ReducedHolders
Q2 202527,942$4.82M2.3%−1,732−5.8%ReducedHolders
Q1 202529,674$4.62M2.4%−822−2.7%ReducedHolders
Q4 202430,496$4.20M2.1%−3,188−9.5%ReducedHolders
Q3 202433,684$5.03M2.4%−1,045−3.0%ReducedHolders
Q2 202434,729$4.74M2.3%−811−2.3%ReducedHolders
Q1 202435,540$5.37M2.6%+905+2.6%AddedHolders
Q4 202334,635$4.36M2.3%+8,380+31.9%AddedHolders
Q3 202326,255$2.46M1.7%−5,695−17.8%ReducedHolders
Q2 202331,950$2.85M1.8%+3,800+13.5%AddedHolders
Q1 202328,150$3.02M1.9%−2,370−7.8%ReducedHolders
Q4 202230,520$3.73M3.3%+5,110+20.1%AddedHolders
Q3 202225,410$2.62M3.3%00.0%UnchangedHolders
Q2 202225,410$2.36M2.2%+600+2.4%AddedHolders
Q1 202224,810$2.91M2.7%+970+4.1%AddedHolders
Q4 202123,840$3.21M2.2%+3,930+19.7%AddedHolders
Q3 202119,910$3.17M1.2%+820+4.3%AddedHolders
Q2 202119,090$2.51M0.8%−1,100−5.4%ReducedHolders
Q1 202120,190$2.60M0.7%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.